Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1822 of 6351
-
Can DNA reveal the roots of a rare muscle disease?
Knowledge-focused Recruiting nowThe MuSK myasthenia gravis 1000 study seeks to collect saliva samples from 1000 subjects with laboratory confirmed diagnosis of MuSK myasthenia to identify genetic variations associated with MuSK MG. The data collected may be used by researchers to gain a better understanding of …
Sponsor: George Washington University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Brain training for the spine: new study aims to reduce spasticity and boost walking
Symptom relief Recruiting nowThe purpose of this study is to validate the capacity of a reflex training system to change the size of the targeted reflex. For this, the researchers are recruiting 25 individuals with chronic incomplete SCI who have spasticity in the leg to participate in the reflex training pr…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 26, 2026 15:09 UTC
-
Could flickering light boost brain health in Alzheimer's?
Symptom relief Recruiting nowParticipants will randomly be placed into one of four groups and experience one of the four following conditions: (1) a placebo light that provides a 40 hertz (Hz) flicker (rhythmic light \[RL\]); (2) a placebo light with a random flicker (placebo condition for rhythmic light); (…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Experimental vaccine targets breast cancer cells in the brain
Disease control OngoingThe purpose of this study is to learn about the effects of the study treatment, Dendritic Cell Vaccine (DCV), to find the highest dose of the study treatment that can be given safely to Breast Cancer patients with Leptomeningeal Disease
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New shots aim to soothe severe eczema in major pfizer trial
Symptom relief Recruiting nowThe purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic dermatitis (AD). AD is a long- lasting itchy red rash, caused by a skin reaction. This study is seeking participants who: * are 18 y…
Phase 2 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Online therapy plus pill may cut Kids' migraines in half
Prevention Recruiting nowThis comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) vi…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Can a digital weight program and glucose monitor help control diabetes?
Disease control CompletedThis study is a randomized clinical trial with the primary aim examining the efficacy of a novel integrated solution of a digitally delivered behavioral weight management program tailored for diabetes utilizing a continuous glucose monitor (CGM) built into the WW digital platform…
Sponsor: Pennington Biomedical Research Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a cholesterol drug help fight a rare liver disease?
Disease control OngoingThe main objectives of the study were to assess the effects of fenofibrate on serum alkaline phosphatase, as a composite endpoint and on safety in participants with primary biliary cholangitis (PBC)
Phase 2/3 • Sponsor: Han Ying • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New drug duo targets hard-to-treat bile duct cancer
Disease control Recruiting nowThis is an open-label, multicenter Phase 1b/2a study to evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of GNS561 in combination with trametinib in Advanced KRAS Mutated Cholangiocarcinoma after failure of standard-of-care first line therapy
Phase 1/2 • Sponsor: Genfit • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New strategy could slash antibiotic overuse in sick kids
Disease control Recruiting nowThe goal of this quasi-experimental interventional study is to determine the effectiveness of a multifaceted stewardship intervention in reducing overall vancomycin use in five tertiary care Pediatric Intensive Care Units (PICU). There are two groups of subjects in this study: P…
Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 26, 2026 19:15 UTC
-
One-Shot knee injection could ease arthritis pain
Symptom relief OngoingIn this clinical trial the investigator assess the safety and efficacy of a single injection of a combination of cross-linked hyaluronic acid (HA) with autologous platelet-rich plasma (PRP) obtained with the RegenMatrix medical device to improve symptoms of moderate to severe kne…
Sponsor: RegenLab France SAS • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New combo aims to tackle tough uterine cancer
Disease control Recruiting nowImmunotherapy has gained a significant amount of attention recently, but its efficacy as a single agent in gynecological cancers has been disappointing. Pre-clinical evidence supports the combination of using Vascular Endothelial Growth Factors (VEGF) inhibitors with immunotherap…
Phase 1/2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a brain zap boost therapy for borderline personality disorder?
Symptom relief OngoingThis project assesses the effectiveness and lasting impact of combining Dialectical Behavioral Therapy (DBT) with prefrontal repetitive transcranial magnetic stimulation (rTMS) in patients with borderline personality disorder.
Sponsor: Masarykova Univerzita • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Could a common diabetes drug tame ulcerative colitis?
Disease control Recruiting nowThe inflammatory bowel diseases (IBD) are described as complex, recurrent inflammatory conditions which are manifested as Crohn's disease (CD) and ulcerative colitis (UC). The common symptoms of IBD include debilitating/severe diarrhea, abdominal pain, weight loss, and chronic fa…
Phase 2/3 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New gel and glue combo takes on stubborn, smelly wounds
Disease control OngoingThe aim of this study is to eliminate the malodorous of chronic wound and increase the chance of the healing of recalcitrant wounds by using the repairing gel (supraz gel) which has the approved components in wound healing and platelet-rich plasma-fibrin glue.
Phase 2/3 • Sponsor: Mashhad University of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can strength training rewire the brain?
Knowledge-focused CompletedThe novelty of this study is to identify the mechanism of nervous system by applying resistance training intervention in healthy individuals.
Sponsor: Pakistan Society for Rehabilitation of Differently Abled Hospital • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Experimental combo targets Hard-to-Treat lung cancer mutations
Disease control OngoingTo learn if the combination of sarilumab (also called Kevzara) and cemiplimab can help to control EGFR- or LKB1/STK11-mutant NSCLC.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can tighter blood pressure control shield hearts during breast cancer therapy?
Disease control Recruiting nowThe purpose of this study to find out whether an intensive approach to treating high blood pressure during breast cancer treatment is safe and more effective than standard blood pressure treatment at lowering blood pressure levels and the risk of cardiotoxicity in patients with c…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug doses tested for rare blood cancer
Disease control CompletedThis is A Randomized,Open-label, Multicenter, Phase II Trial Evaluating Two Different Doses of Orelabrutinib in Mantle Cell Lymphoma to Evaluate the Efficacy and Safety in Mantle Cell Lymphoma.
Phase 2 • Sponsor: InnoCare Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a simple blood test predict heart trouble in childhood cancer survivors?
Knowledge-focused Recruiting nowThis study assesses how blood cell growth patterns (clonal hematopoiesis) relate to heart health or cardiovascular disease (CVD) after treatment in patients with Hodgkin lymphoma. In some patients, cancer treatment at a young age may lead to later complications, including problem…
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC